Genomics into health
As genomic experts, we have a comprehensive understanding of how innovative technologies can contribute to more effective healthcare
We work with policy-makers, clinicians, academia and industry to develop future-focused healthcare strategies for safe and suitable use of innovations, such as diagnostics, genome editing and regenerative medicines. Only through understanding the benefits - and complexities - of genomics-based innovations and other 'omics sciences can we help everyone benefit from great science.
Explainer Pandemic in the genomic era
Genomics is proving its worth in the battle against infectious disease, including COVID-19.
Report Polygenic scores and clinical utility
Our report unpicks the complexities of assessing the clinical utility of polygenic scores
Report Pathogen Genomics Into Practice
Converting genomics into population wide, high quality, evidence based pathogen services
Blog Expanding the public and patient role in medical regulation
6 July 2021
A recent consultation by the UK Medicines and Healthcare products Regulatory Agency (MHRA) indicates a welcome new direction for public and patient involvement (PPI).
Blog Putting Genome UK into practice
18 May 2021
Blog Bringing order to polygenic score reporting
14 April 2021
Inconsistencies in the way polygenic score models are reported could delay their introduction into healthcare. Two very welcome (in our opinion) new papers aim to bring order to the field
Report The ethical and legal framework for a Genomics England and Sano Genetics participant engagement platform
12 April 2021
Commissioned by Genomics England, our new report examines the legal and ethical implications of an online platform for patient engagement in precision medicine research being developed by Sano Genetics
Research Infectious disease and genomics
19 March 2021
Knowledge emerging from the genomic sequencing of pathogens is fuelling more effective interventions to prevent and manage the spread of infectious diseases
Explainer What is clinical utility?
1 March 2021
Evidence of clinical utility is a key requirement of healthcare evaluation frameworks, however, demonstrating this is not straightforward
Blog Personalising therapy for age-related macular degeneration
10 February 2021
Gene therapy holds new hope for AMD patients. If successful they will be beneficial to patients for whom no current therapies are available or do not work.